litlas
ログインアカウント作成

Michael W. Konstan

1990–2025 年に発表

108
論文数
21,856
被引用数
79
h 指数
104
i10 指数

被引用数

Michael W. Konstan の年別被引用数1978 年: 被引用 2 件1983 年: 被引用 2 件1990 年: 被引用 1 件1991 年: 被引用 3 件1993 年: 被引用 1 件1994 年: 被引用 5 件1995 年: 被引用 13 件1996 年: 被引用 20 件1997 年: 被引用 42 件1998 年: 被引用 49 件1999 年: 被引用 79 件2000 年: 被引用 77 件2001 年: 被引用 97 件2002 年: 被引用 117 件2003 年: 被引用 115 件2004 年: 被引用 108 件2005 年: 被引用 109 件2006 年: 被引用 95 件2007 年: 被引用 162 件2008 年: 被引用 130 件2009 年: 被引用 110 件2010 年: 被引用 124 件2011 年: 被引用 152 件2012 年: 被引用 148 件2013 年: 被引用 175 件2014 年: 被引用 201 件2015 年: 被引用 191 件2016 年: 被引用 256 件2017 年: 被引用 228 件2018 年: 被引用 187 件2019 年: 被引用 717 件2020 年: 被引用 716 件2021 年: 被引用 802 件2022 年: 被引用 458 件2023 年: 被引用 393 件2024 年: 被引用 436 件2025 年: 被引用 169 件1979〜1982 年は被引用が無いため表示していません1984〜1989 年は被引用が無いため表示していません1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,863 件、この内訳の 32.4%イギリス: 引用元論文 580 件、この内訳の 10.1%カナダ: 引用元論文 383 件、この内訳の 6.7%ドイツ: 引用元論文 339 件、この内訳の 5.9%イタリア: 引用元論文 330 件、この内訳の 5.8%フランス: 引用元論文 270 件、この内訳の 4.7%オーストラリア: 引用元論文 260 件、この内訳の 4.5%オランダ: 引用元論文 199 件、この内訳の 3.5%ベルギー: 引用元論文 138 件、この内訳の 2.4%中国: 引用元論文 131 件、この内訳の 2.3%アイルランド: 引用元論文 122 件、この内訳の 2.1%スイス: 引用元論文 98 件、この内訳の 1.7%
0%32.4%その他 17.9%

機関

分野

  • Medicine76.3%
  • Biochemistry, Genetics and Molecular Biology13.2%
  • Immunology and Microbiology4.4%
  • Environmental Science0.9%
  • Health Professions0.8%
  • Engineering0.7%
  • その他3.7%

トピック

  • Cystic Fibrosis Research Advances22.5%
  • Neonatal Respiratory Health Research9.3%
  • Tracheal and airway disorders4%
  • Asthma and respiratory diseases3.2%
  • Inhalation and Respiratory Drug Delivery3%
  • Bacterial biofilms and quorum sensing2.9%
  • その他55.1%

共著者

全論文

検索で開く
  1. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation

    著者: Bonnie W. Ramsey, Jane C. Davies, Noel G. McElvaney, Elizabeth Tullis, Scott C. Bell, Pavel Dřevínek, Matthias Griese, Edward F. McKone, Claire Wainwright, Michael W. Konstan, Richard B. Moss, Félix Ratjen, Isabelle Sermet‐Gaudelus, Steven M. Rowe, Qunming Dong, Sally Rodriguez, Karl Yen, Claudia L. Ordoñez, J.S. Elborn - New England Journal of Medicine 2011 被引用: 2,174

  2. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR

    著者: Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey, Gautham Marigowda, Xiaohong Huang, Marco Cipolli, Carla Colombo, Jane C. Davies, K. De Boeck, Patrick A. Flume, Michael W. Konstan, Susanna A. McColley, Karen McCoy, Edward F. McKone, À. Munck, Félix Ratjen, Steven M. Rowe, David Waltz, Michael Boyle - New England Journal of Medicine 2015 被引用: 1,621

  3. Increasing life expectancy in cystic fibrosis: Advances and challenges

    著者: Kimberly McBennett, Pamela B. Davis, Michael W. Konstan - Pediatric Pulmonology 2021 被引用: 140

  4. The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices

    著者: Sharon Walsh, Nabila El‐Bassel, Rebecca D. Jackson, Jeffrey H. Samet, Maneesha Aggarwal, Arnie Aldridge, Trevor Baker, Carolina Barbosa, Joshua A. Barocas, Tracy A. Battaglia, Donna Beers, Dana Bernson, Rachel Bowers-Sword, Carly Bridden, Jennifer L. Brown, Heather Bush, Joshua Bush, Amy Button, Aimee Campbell, Magdalena Cerdá, Debbie M. Cheng, Jag Chhatwal, Thomas Clarke, Kevin P. Conway, Erika L. Crable, Andrea Czajkowski, James L. David, Mari‐Lynn Drainoni, Laura Fanucchi, Daniel J. Feaster, Soledad Fernández, Darcy A. Freedman, Bridget Freisthler, Louisa Gilbert, LaShawn Glasgow, Dawn Goddard‐Eckrich, Damara Gutnick, Kristin Harlow, Donald W. Helme, Terry T.‐K. Huang, Timothy R. Huerta, Timothy Hunt, Ayaz Hyder, Robin Kerner, Katherine M. Keyes, Charles Knott, Hannah K. Knudsen, Michael W. Konstan, Marc R. Larochelle, R. Craig Lefebvre, Frances R. Levin, Nicky Lewis, Benjamin P. Linas, Michelle R. Lofwall, David W. Lounsbury, Michael S. Lyons, Sarah Mann, Katherine R. Marks, Ann Scheck McAlearney, Kathryn E. McCollister, Tara McCrimmon, Jennifer Miles, C. Miller, Denis Nash, Edward V. Nunes, Emmanuel Oga, Carrie B. Oser, Tracy J. Plouck, Bruce D. Rapkin, Patricia R. Freeman, Sandra Rodríguez, Elisabeth Dowling Root, Lisa Rosen-Metsch, Nasim S. Sabounchi, Richard Saitz, Pamela J. Salsberry, Caroline Savitsky, Bruce R. Schackman, Eric E. Seiber, Michael D. Slater, Svetla Slavova, Drew Speer, Linda Sprague Martínez, Leyla Stambaugh, Michele Staton, Michael D. Stein, Danelle Stevens‐Watkins, Hilary L. Surratt, Jeffery Talbert, Katherine Thompson, Kim Toussant, Nathan Vandergrift, Jennifer Villani, Daniel M. Walker, Alexander Y. Walley, Scott T. Walters, Philip M. Westgate, Theresa Winhusen, Elwin Wu, April M. Young ほか 3 名 - Drug and Alcohol Dependence 2020 被引用: 153

  5. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy

    著者: André M. Cantin, Dominik Hartl, Michael W. Konstan, James F. Chmiel - Journal of Cystic Fibrosis 2015 被引用: 486

  6. Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries

    著者: Nataliya Volkova, Kristin A. Moy, Jennifer Evans, Daniel Campbell, Simon Tian, C Simard, Mark Higgins, Michael W. Konstan, Gregory S. Sawicki, Alexander Elbert, Susan C. Charman, Bruce C. Marshall, Diana Bilton - Journal of Cystic Fibrosis 2019 被引用: 255

  7. Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor

    著者: Leona Bessonova, Nataliya Volkova, Mark Higgins, Leif Bengtsson, Simon Tian, C Simard, Michael W. Konstan, Gregory S. Sawicki, A. Sewall, Stephen Nyangoma, Alexander Elbert, Bruce C. Marshall, Diana Bilton - Thorax 2018 被引用: 213

  8. Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation

    著者: Daniel Gelfond, Sonya L. Heltshe, Chang‐Xing Ma, Steven M. Rowe, Carla Frederick, Ahmet Uluer, Leonard Sicilian, Michael W. Konstan, Elizabeth Tullis, Christine R N Roach, Katherine Griffin, Elizabeth Joseloff, Drucy Borowitz - Clinical and Translational Gastroenterology 2017 被引用: 150

  9. Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis

    著者: Diana Bilton, Tacjana Pressler, Isabelle Fajac, John P. Clancy, Dorota Sands, Predrag Minić, Marco Cipolli, Ivanka Galeva, Amparó Solé, Alexandra L. Quittner, Keith Liu, John P. McGinnis, Gina Eagle, Renu Gupta, Michael W. Konstan, Sabine Renner, Christiane Knoop, Anne Malfroot, Lieven Dupont, Kristine Desager, Frans De Baets, Miroslava Bosheva, V. Nedkova, Ivan Galabov, Ivanka Galeva, Andreas Freitag, Nancy Morrison, Pearce Wilcox, T. Pressler, Yves Martinet, R. Chiron, Isabelle Fajac, Stephan Dominique, Philippe Reix, Anne Prévötat, Isabelle Sermet‐Gaudelus, I. Durieu, Rainald Fischer, Rudolf M. Huber, Doris Staab, Uwe Mellies, Wolfgang Sextro, Tobias Welte, Heinrike Wilkens, Urte Sommerwerk, Burkhard Bewig, I. Inglezos, Stavros‐Eleftherios Doudounakis, Olga Bede, Ferenc Gönczi, Rita Újhelyi, Edward F. McKone, Paul McNally, V. Lucidi, Marco Cipolli, Mario La Rosa, L. Minicucci, Rita Padoan, Giovanna Pisi, R. Gagliardini, Carla Colombo, Inez Bronsveld, Ewa Sapiejka, Henryk Mazurek, Dorota Sands, G Górnicka, Iwona Stelmach, Halina Batura‐Gabryel, Marta Rachel, Predrag Minić, Jaroslava Orosova, Branko Takac, A. Feketova, Carmen Montero Martínez, Gloria Garcia Hernandez, José Ramón Villa-Asensi, Silvia Gärtner, Amparó Solé, Anders Lindblad, M.J. Ledson, Diana Bilton, J.L. Whitehouse, Alan R Smyth, I. Ketchell, Timothy Lee, Gordon MacGregor - Journal of Cystic Fibrosis 2019 被引用: 54

  10. KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa

    著者: Raksha Jain, Valeria Beckett, Michael W. Konstan, Frank J. Accurso, Jane L. Burns, Nicole Mayer-Hamblett, Carlos Milla, Donald R. VanDevanter, James F. Chmiel - Journal of Cystic Fibrosis 2017 被引用: 106

  11. Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- CFTR Mutation

    著者: Frank J. Accurso, Steven M. Rowe, John P. Clancy, Michael Boyle, Jordan Dunitz, Peter R. Durie, Scott D. Sagel, Douglas B. Hornick, Michael W. Konstan, Scott H. Donaldson, Richard B. Moss, Joseph M. Pilewski, Ronald C. Rubenstein, Ahmet Uluer, Moira L. Aitken, Steven D. Freedman, Lynn M. Rose, Nicole Mayer-Hamblett, Qunming Dong, Jiuhong Zha, Anne J. Stone, Eric R. Olson, Claudia L. Ordoñez, Preston W. Campbell, Melissa A. Ashlock, Bonnie W. Ramsey - New England Journal of Medicine 2010 被引用: 802

  12. Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection

    著者: John P. Clancy, Lieven Dupont, Michael W. Konstan, Joanne Billings, S. Fustik, Christopher H. Goss, James Lymp, Predrag Minić, Alexandra L. Quittner, Ronald C. Rubenstein, K. Randall Young, Lisa Saiman, Jane L. Burns, John R. W. Govan, Bonnie W. Ramsey, Renu Gupta, for the Arikace Study Group - Thorax 2013 被引用: 219

  13. Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

    著者: Nicole Mayer-Hamblett, John P. Clancy, Raksha Jain, Scott H. Donaldson, Isabelle Fajac, Christopher H. Goss, Deepika Polineni, Félix Ratjen, Bradley S. Quon, Edith T. Zemanick, Scott C. Bell, Jane C. Davies, Manu Jain, Michael W. Konstan, Natanya R. Kerper, Tré LaRosa, Marcus Mall, Edward F. McKone, Kelsie Pearson, Joseph M. Pilewski, Lynne M. Quittell, Jonathan H. Rayment, Steven M. Rowe, Jennifer L. Taylor‐Cousar, George Retsch‐Bogart, D.G. Downey - The Lancet Respiratory Medicine 2023 被引用: 33

  14. Sustained Benefit from Ivacaftor Demonstrated by Combining Clinical Trial and Cystic Fibrosis Patient Registry Data

    著者: Gregory S. Sawicki, Edward F. McKone, David J. Pasta, Stefanie J. Millar, Jeffrey S. Wagener, Charles A. Johnson, Michael W. Konstan - American Journal of Respiratory and Critical Care Medicine 2015 被引用: 239

  15. Association between Pulmonary Function and Sputum Biomarkers in Cystic Fibrosis

    著者: Nicole Mayer-Hamblett, Moira L. Aitken, Frank J. Accurso, Richard A. Kronmal, Michael W. Konstan, Jane L. Burns, Scott D. Sagel, Bonnie W. Ramsey - American Journal of Respiratory and Critical Care Medicine 2007 被引用: 225

  16. Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection

    著者: Diana Bilton, Isabelle Fajac, Tacjana Pressler, John P. Clancy, Dorota Sands, Predrag Minić, Marco Cipolli, Ivanka Galeva, Amparó Solé, Alexandra L. Quittner, Zhanna Jumadilova, Monika Ciesielska, Michael W. Konstan - Journal of Cystic Fibrosis 2021 被引用: 26

  17. A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial

    著者: Michael Boyle, Scott C. Bell, Michael W. Konstan, Susanna A. McColley, Steven M. Rowe, Ernst Rietschel, Xiaohong Huang, David Waltz, Naimish Patel, David M. Rodman - The Lancet Respiratory Medicine 2014 被引用: 442

  18. Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator Reconstitution

    著者: Michael W. Konstan, Pamela B. Davis, Jeffrey S. Wagener, Kathleen A. Hilliard, Robert C. Stern, Laura Milgram, T. Kowalczyk, Susannah L. Hyatt, Tamara L. Fink, Christopher R. Gedeon, Sharon M. Oette, Jennifer M. Payne, Osman Muhammad, Assem Ziady, Robert C. Moen, Mark J. Cooper - Human Gene Therapy 2004 被引用: 296

  19. Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study

    著者: Michael W. Konstan, Edward F. McKone, Richard B. Moss, Gautham Marigowda, Simon Tian, David Waltz, Xiaohong Huang, Barry Lubarsky, Jaime Rubin, Stefanie J. Millar, David J. Pasta, Nicole Mayer-Hamblett, Christopher H. Goss, Wayne J. Morgan, Gregory S. Sawicki - The Lancet Respiratory Medicine 2016 被引用: 286

  20. Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis

    著者: J.S. Elborn, Bonnie W. Ramsey, Michael Boyle, Michael W. Konstan, Xiaohong Huang, Gautham Marigowda, David Waltz, Claire Wainwright - The Lancet Respiratory Medicine 2016 被引用: 155

  21. Anti-PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection

    著者: Carlos Milla, James F. Chmiel, Frank J. Accurso, Donald R. VanDevanter, Michael W. Konstan, Geoffrey Yarranton, David E. Geller, for the KB001 Study Group - Pediatric Pulmonology 2013 被引用: 110

  22. Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design

    著者: Nicole Mayer-Hamblett, David P. Nichols, Katherine Odem‐Davis, Kristin A. Riekert, G. Sawicki, Scott H. Donaldson, Félix Ratjen, Michael W. Konstan, Noah Simon, Daniel Rosenbluth, George Retsch‐Bogart, John Clancy, Jill M. VanDalfsen, Rachael Buckingham, Alex H. Gifford - Annals of the American Thoracic Society 2021 被引用: 58

  23. Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease

    著者: Scott D. Sagel, James F. Chmiel, Michael W. Konstan - American Thoracic Society, Proceedings of the American Thoracic Society 2007 被引用: 174

  24. Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis

    著者: Richard B. Moss, Sunil Mistry, Michael W. Konstan, Joseph M. Pilewski, Eitan Kerem, Ruth Tal‐Singer, Aili L. Lazaar - Journal of Cystic Fibrosis 2012 被引用: 112